Breastfeeding and infant growth in offspring of mothers with hyperglycaemia in pregnancy: The pregnancy and neonatal diabetes outcomes in remote Australia study

BACKGROUND

Benefits of breastfeeding on infant growth in children born to mothers with gestational diabetes mellitus (GDM) are uncertain.

OBJECTIVES

To describe growth trajectories between birth and 14 months according to breastfeeding and maternal hyperglycaemia in pregnancy, and assess associations between breastfeeding and 14 month growth outcomes among children born to mothers with GDM.

SUBJECTS/METHODS

Data on 258 Aboriginal and Torres Strait Islander infants from the PANDORA study born to mothers with normoglycaemia (n = 73), GDM (n = 122), or with pre-existing type 2 diabetes (n = 63) in pregnancy were assessed. Infant weight and BMI growth trajectories according to predominant breastfeeding at 6 months and hyperglycaemia in pregnancy were developed using mixed-effect models and cubic splines. Associations between breastfeeding and 14-month growth outcomes (z-scores: weight-for-age, weight-for-length and BMI) were evaluated using linear regression in a subgroup of infants born to mothers with GDM.

RESULTS

Predominantly breastfed infants had lower BMI trajectories compared to those not predominantly breastfed, irrespective of maternal hyperglycaemia in pregnancy status (p < 0.01 for all groups), and lower weight trajectories among those born to mothers with GDM (p = 0.006). Among offspring of women with GDM, predominant breastfeeding was only associated with lower weight-for-age at 14 months, however adjusting for maternal obesity, smoking, and parity attenuated observed associations. Maternal obesity remained significantly associated with greater infant growth.

CONCLUSIONS

Predominant breastfeeding was associated with reduced growth among children born to women with and without hyperglycaemia in pregnancy. However, among children exposed to GDM in utero, maternal obesity largely explained this association.

Associations of gestational diabetes and type 2 diabetes during pregnancy with breastfeeding at hospital discharge and up to 6 months: the PANDORA study

AIMS/HYPOTHESIS

Women with gestational diabetes mellitus (GDM) and obesity experience lower rates of breastfeeding. Little is known about breastfeeding among mothers with type 2 diabetes. Australian Indigenous women have a high prevalence of type 2 diabetes in pregnancy. We aimed to evaluate the association of hyperglycaemia, including type 2 diabetes, with breastfeeding outcomes.

METHODS

Indigenous (n = 495) and non-Indigenous (n = 555) participants of the Pregnancy And Neonatal Diabetes Outcomes in Remote Australia (PANDORA) cohort included women without hyperglycaemia in pregnancy (n = 222), with GDM (n = 684) and with type 2 diabetes (n = 144). The associations of hyperglycaemia in pregnancy and breastfeeding at hospital discharge, 6 weeks and 6 months post-partum were evaluated with logistic regression, after adjustment for maternal obesity, ethnicity, maternal and neonatal characteristics.

RESULTS

Indigenous women were more likely to predominantly breastfeed at 6 weeks across all levels of hyperglycaemia. Compared with women with no hyperglycaemia in pregnancy, women with type 2 diabetes had lower odds for exclusive breastfeeding at discharge (adjusted OR for exclusive breastfeeding 0.4 [95% CI 0.2, 0.8] p = 0.006). At 6 weeks and 6 months, the relationship between type 2 diabetes and predominant breastfeeding was not statistically significant (6 weeks 0.7 [0.3, 1.6] p = 0.40, 6 months 0.8 [0.4, 1.6] p = 0.60). Women with gestational diabetes were as likely to achieve predominant breastfeeding at 6 weeks and 6 months as women without hyperglycaemia in pregnancy.

CONCLUSIONS/INTERPRETATION

Indigenous women had high rates of breastfeeding. Women with type 2 diabetes had difficulty establishing exclusive breastfeeding at hospital discharge. Further research is needed to assess the impact on long-term breastfeeding outcomes. Graphical abstract.

Effect of a family-centered, secondhand smoke intervention to reduce respiratory illness in indigenous infants in Australia and New Zealand: a randomized controlled trial

INTRODUCTION

Secondhand smoke (SHS) is a significant cause of acute respiratory illness (ARI) and 5 times more common in indigenous children. A single-blind randomized trial was undertaken to determine the efficacy of a family centered SHS intervention to reduce ARI in indigenous infants in Australia and New Zealand.

METHODS

Indigenous mothers/infants from homes with ≥ 1 smoker were randomized to a SHS intervention involving 3 home visits in the first 3 months of the infants' lives (plus usual care) or usual care. The primary outcome was number of ARI-related visits to a health provider in the first year of life. Secondary outcomes, assessed at 4 and 12 months of age, included ARI hospitalization rates and mothers' report of infants' SHS exposure (validated by urinary cotinine/creatinine ratios [CCRs]), smoking restrictions, and smoking cessation.

RESULTS

Two hundred and ninety-three mother/infant dyads were randomized and followed up. Three quarters of mothers smoked during pregnancy and two thirds were smoking at baseline (as were their partners), with no change for more than 12 months. Reported infant exposure to SHS was low (≥ 95% had smoke-free homes/cars). Infant CCRs were higher if one or both parents were smokers and if mothers breast fed their infants. There was no effect of the intervention on ARI events [471 intervention vs. 438 usual care (reference); incidence rate ratio = 1.10, 95% confidence intervals (CI) = 0.88-1.37, p = .40].

CONCLUSIONS

Despite reporting smoke-free homes/cars, mothers and their partners continue to smoke in the first year of infants' lives, exposing them to SHS. Emphasis needs to be placed on supporting parents to stop smoking preconception, during pregnancy, and postnatal.

Food chain aspects of chlordane poisoning in birds and bats

We have observed recurring chlordane poisonings of large numbers of common grackles (Quiscalus quiscula), European starlings (Sturnus vulgaris), and American robins (Turdus migratorius) at suburban roosts in New Jersey during the month of July. This paper describes aspects of the food chain uptake of chlordane that account for the periodicity of these poisonings. Chlordane concentrations ranged from < 0.02 to 20.3 microg/g wet weight in 11 soil samples collected from residential lawns and a golf course near one roost. Of the 10 species of insects and soil invertebrates collected from the area, two scarab beetles, the oriental beetle (Anomala orientalis) and Japanese beetle (Popilla japonica), had the highest concentrations of chlordane-related compounds (15.1 and 5.9 microg/g wet weight, respectively). Concentrations in the other eight species ranged from < 0.04 to 1.3 microg/g. Oriental and Japanese beetles collected from a rural location had concentrations of 0.03 and < 0.02 microg/g, respectively. Emergence of adult beetles peaked in mid- to late July, when bird mortality also peaked. Fecal pellets collected near the roost (n = 24) contained the remains of 1-5 beetles each (mean = 2), and scarab beetles accounted for 40% of the total number of insect parts in the stomach contents of common grackles (n = 8). Unlike soil samples, in which cis- and trans-chlordane predominated, beetles contained large amounts of the more toxic metabolites heptachlor epoxide and oxychlordane. Total chlordane-related compounds ranged from < 0.05 to 18.4 microg/g in Japanese beetles collected from 16 sites in New Jersey and 2 sites in Ohio. The highest concentrations were found in beetles from suburban areas and golf courses. We also analyzed brain tissue from insectivorous bats (15 big brown bats, Eptesicus fuscus, and 5 little brown bats, Myotis lucifugus) that were submitted to the New Jersey Rabies Laboratory in late June/July 1998 and 1999 but found to be rabies-negative. We suggest that high concentrations in three of the bats caused debility or abnormal behavior that may have precipitated submission for rabies testing.